Sperogenix Therapeutics is Other Healthcare Services in China that focus on business expansion services business. Founded in 2015. They cover business area such as operator, rare disease product commercialization, China, clinical development, customer communication, business expansion service, medical business, late clinical stage, benefit, million, rare disease patient.
2015
( 9 years old in 2024 )
Business Expansion Services
-
A-216
No.56 Dongzhimen Wai Xie St. Chaoyang District
Beijing, 100027
China
Private
operatorrare disease product commercializationChinaclinical developmentcustomer communicationbusiness expansion servicemedical businesslate clinical stagebenefitmillionrare disease patient
* We use standard office opening hours in near Sperogenix Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sperogenix Therapeutics is Other Healthcare Services business from China that founded in 2015 (9 years old in 2024), Sperogenix Therapeutics business is focusing on Business Expansion Services.
Sperogenix Therapeutics headquarter office and corporate office address is located in A-216 No.56 Dongzhimen Wai Xie St. Chaoyang District Beijing, 100027 China.
Sperogenix Therapeutics was founded in China.
In 2024, Sperogenix Therapeutics is currently focus on business expansion services sector.
Above is snippet of Google Trends for "business expansion services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sperogenix Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
